CN1891284A - Chinese medicine composition, and its preparing method and quality control method - Google Patents
Chinese medicine composition, and its preparing method and quality control method Download PDFInfo
- Publication number
- CN1891284A CN1891284A CN 200510200384 CN200510200384A CN1891284A CN 1891284 A CN1891284 A CN 1891284A CN 200510200384 CN200510200384 CN 200510200384 CN 200510200384 A CN200510200384 A CN 200510200384A CN 1891284 A CN1891284 A CN 1891284A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- solution
- weight
- preparation
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese medicine composition for effectively curing seborrheic baldness and alopecia areata with good therapeutic effect. Said Chinese medicine composition is made up by using 29 Chinese medicinal materials of flowery knotweed, Chinese angelica foot, poria, astragalus root, carthamus flower, salvia root and others through a certain preparation process. Said invention also provides its preparation process and its quality control method.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of seborrheic alopecia and alopecia areata, also relate to the preparation method and the method for quality control of this Chinese medicine composition simultaneously, belong to the field of Chinese medicines.
Background technology
Alopecia is commonly encountered diseases, frequently-occurring disease clinically, because alopecia influences outward appearance, brings certain mental pressure to the patient.The clinical treatment method is many based on external used medicine, but the articles for use that are used for black hair mostly are chemical dye, the heavy metal problem that it contains has had a strong impact on its application aspect black hair, the absorption of hair changed hair quality when the black hair shampoo of Chu Xianing was once attempted by hair washing in recent years, but the result is all undesirable.
Traditional medicine thinks that poliosis is that QI and blood declines and causes owing to deficiency of kidney-QI.Relevant oral Chinese patent medicine, as: " Qibao Meiran Dan ", " bolus of ten powerful tonics " etc. are intended to adopt the method for enriching yin and nourishing kidney to reach the purpose of black hair, but many meetings of suffering from a deficiency of the kidney are with insufficiency of the spleen, the medicine of taking enriching yin and nourishing kidney for a long time can make that the patient produces that big loose stool is thin, diarrhoea or wetly contain fullness in the epigastrium and abdomen and disease such as stagnant, has increased unnecessary misery and stress to the patient.The purpose of this invention is to provide a kind of can replenishing QI to invigorate the spleen, disperse blood stasis and dredge collateral, the Chinese medicine composition of blood nourishing and hair.Can be used for insufficiency of the spleen leading to overabundance of dampness, the seborrheic alopecia of caused by energy stagnation and blood stasis and alopecia areata.
Summary of the invention
The present invention seeks to be achieved through the following technical solutions
Medicine of the present invention is made by following component:
Radix Polygoni Multiflori 5-10 weight portion Radix Angelicae Sinensis 20-25 weight portion Cortex Magnoliae Officinalis 7-12 weight portion
Poria 7-12 weight portion Semen Plantaginis 7-12 weight portion Radix Saposhnikoviae 1-5 weight portion
Rhizoma Alismatis 7-12 weight portion Fructus Aurantii 50-55 weight portion Polyporus 10-15 weight portion
Radix Astragali 15-20 weight portion Pericarpium Citri Reticulatae Viride 15-20 weight portion Radix Codonopsis 30-35 weight portion
Flos Carthami 35-40 weight portion Semen Persicae 30-35 weight portion Radix Bupleuri 30-35 weight portion
Rhizoma Chuanxiong 50-55 weight portion Semen Coicis 30-35 weight portion Radix Paeoniae Rubra 30-35 weight portion
Herba Lycopi 30-35 weight portion Radix Salviae Miltiorrhizae 30-35 weight portion Rhizoma Corydalis 30-35 weight portion
Rhizoma Atractylodis 165-170 weight portion Rhizoma Atractylodis Macrocephalae 65-70 weight portion Herba Pogostemonis 37-45 weight portion
Herba Eupatorii 37-45 weight portion Pericarpium Citri Reticulatae 100-105 weight portion Rhizoma Pinelliae 7-12 weight portion
Radix Angelicae Dahuricae 50-55 weight portion Radix Platycodonis 30-35 weight portion.
Medicine optimum weight part proportioning of the present invention is:
Radix Polygoni Multiflori 7 weight portion Radix Angelicae Sinensis 24 weight portion Cortex Magnoliae Officinalis 10 weight portions
Poria 10 weight portion Semen Plantaginiss 10 weight portion Radix Saposhnikoviaes 3 weight portions
Rhizoma Alismatis 10 weight portion Fructus Aurantiis 54 weight portion Polyporus 13 weight portions
The Radix Astragali 17 weight portion Pericarpium Citri Reticulatae Virides 17 weight portion Radix Codonopsis 34 weight portions
Flos Carthami 37 weight portion Semen Persicaes 34 weight portion Radix Bupleuri 34 weight portions
Rhizoma Chuanxiong 54 weight portion Semen Coiciss 34 weight portion Radix Paeoniae Rubra 34 weight portions
Herba Lycopi's 34 weight portion Radix Salviae Miltiorrhizaes 34 weight portion Rhizoma Corydalis 34 weight portions
The Rhizoma Atractylodis 169 weight portion Rhizoma Atractylodis Macrocephalaes 67 weight portion Herba Pogostemonis 40 weight portions
The Herba Eupatorii 40 weight portion Pericarpium Citri Reticulataes 101 weight portion Rhizoma Pinelliaes 10 weight portions
The Radix Angelicae Dahuricae 54 weight portion Radix Platycodoniss 34 weight portions
And in the above flavour of a drug, Radix Polygoni Multiflori is preferably Radix Polygoni Multiflori Preparata, states in vain and is preferably Rhizoma Atractylodis Macrocephalae (parched), and the Rhizoma Pinelliae is preferably Rhizoma Pinelliae Preparata clearly.
Above crude drug in conjunction with the pharmaceutics technology, can be made clinical required multiple dosage form, as tablet, capsule, soft capsule, pill, powder etc.But the preparation of these dosage forms is similar, and basic process is: above crude drug is ground into fine powder, adds suitable adjuvant, make required dosage form.
This wherein, preferred pill is a most preferred dosage form, its preparation process is: get crude drug, be ground into fine powder, cross 100 mesh sieves, mixing is made pill.This pill can be the watered pill made from water, also can be to add the honeyed pill that processed with honey becomes, and also can be the water-honeyed pill of making together with water and honey.
In research process of the present invention, the invention Human Factor Research needs and formulates and used a cover method of quality control, and this method guarantees that for the quality of control product of the present invention its effectiveness plays an important role.Divide assay and qualitative identification two parts in the method, below narration respectively.
Content assaying method can adopt in the following several method one or more according to the needs of different dosage form:
A, high effective liquid chromatography for measuring Determination of Hesperidin Content
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; 15: 85-25: 75 acetonitrile-water is a mobile phase; The detection wavelength is 284 ± 2nm; Number of theoretical plate calculates by the Hesperidin peak should be not less than 2000;
It is an amount of that the preparation precision of reference substance solution takes by weighing the Hesperidin reference substance, adds methanol and make the solution that every 1ml contains 50-100 μ g, promptly;
It is an amount of that this product is got in the preparation of need testing solution, accurate claims surely, puts in the conical flask, and precision adds methanol 25-100ml, claim decide weight, and supersound process 20-40 minute, take out, put coldly, claim to decide weight, supply the weight that subtracts mistake with methanol, filtration is got subsequent filtrate, promptly;
Accurate respectively reference substance solution and each the 5-10 μ l of need testing solution of drawing of algoscopy injects chromatograph of liquid, measures, promptly;
B, high effective liquid chromatography for measuring content of paeoniflorin
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; 10: 90-20: 80 acetonitrile-0.1 phosphoric acid is mobile phase, detects wavelength 230 ± 2nm; Number of theoretical plate calculates by the peoniflorin peak should be not less than 1500;
It is an amount of that the preparation precision of the preparation reference substance solution of reference substance solution takes by weighing in phosphorus pentoxide desiccator 36 hours peoniflorin reference substance of drying under reduced pressure, adds mobile phase and make the solution that contains 40-60 μ g among every 1ml, shakes up, promptly;
It is an amount of that this product is got in the preparation of need testing solution, and accurate the title decides, and the accurate methanol 25-100ml that adds claims to decide weight, and supersound process 20-40 minute, claim again to decide weight, add methanol and supply the weight that subtracts mistake, filtration, promptly;
Accurate respectively reference substance solution and each the 5-10 μ l of need testing solution of drawing of algoscopy injects chromatograph of liquid, measures, promptly;
C, high effective liquid chromatography for measuring 2,3,5, the content of 4 '-tetrahydroxystilbene 2-O-β-D-glucoside
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; 10: 90-20: 80 acetonitrile-water is a mobile phase; The detection wavelength is 320 ± 2nm; Number of theoretical plate by 2,3,5,4 '-tetrahydroxystilbene-2-O-β-D-glucoside peak calculates, and should be not less than 2000;
The preparation precision of reference substance solution takes by weighing 2,3,5,4 '-tetrahydroxystilbene-2-O-β-D-glucoside reference substance is an amount of, and add the mobile phase dissolving and make the reference substance solution that every 1ml contains 10-30 μ g, promptly;
It is an amount of that this product is got in the preparation of need testing solution, accurate claims surely, and the accurate Diluted Alcohol 100ml that adds claims decide weight, and supersound process 20-40 minute, put coldly, claim again to decide weight, supply the weight that subtracts mistake with Diluted Alcohol, filtration adds mobile phase to scale, shakes up, promptly;
Accurate respectively reference substance solution and each the 5-10 μ l of need testing solution of drawing of algoscopy injects chromatograph of liquid, measures, promptly.
The qualitative identification method also can be one or more in the following method:
A, to get preparation of the present invention a small amount of, puts microscopically and observe: pollen grain similar round, ellipse or olive shape, diameter be approximately to 60 μ m, 3 germinal aperatures of tool, and outer wall has dentation; Prism of calcium oxalate is present in the mesocarp parenchyma cell in flakes, is multiaspect shape, rhombus or biconial, diameter 3～34 μ m; Calcium oxalate cluster crystal is dispersed in or is present in the parenchyma cell, diameter 20～80 μ m; Irregular particle shape agglomerate and divide dendritic agglomerate colourless is met chloral hydrate liquid and is gradually dissolved, and hyphae colorless or light brown are elongated, and be crooked slightly;
B, to get preparation of the present invention a small amount of, the 20-50ml that adds diethyl ether, and reflux 1 hour filters, and filtrate volatilizes, and the residue 2ml that adds diethyl ether makes dissolving, as need testing solution; Other gets Radix Angelicae Sinensis control medicinal material 1g, shines medical material solution in pairs with legal system; According to the thin layer chromatography test, draw each 2-5 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, be developing solvent with normal hexane-ethyl acetates of 19: 1, launch, take out, dry, put under the ultra-violet lamp 365nm and inspect; In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color;
C, to get preparation of the present invention a small amount of, the 20-50ml that adds diethyl ether, and reflux 1 hour filters, and filtrate volatilizes, and the residue 2ml that adds diethyl ether makes dissolving, as need testing solution; Get Rhizoma Atractylodis control medicinal material 1g, the 15ml that adds diethyl ether, reflux 1 hour filters, and filtrate volatilizes, and the residue 2ml that adds diethyl ether makes dissolving, in contrast medical material solution; According to the thin layer chromatography test, draw each 2-10 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with the normal hexane is developing solvent, launches, and takes out, dry, spray is with 10% ethanol solution of sulfuric acid of 5% paradime thylaminobenzaldehyde, and it is clear to be heated to the speckle colour developing; In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the speckle of same color;
D, to get preparation of the present invention a small amount of, adds methanol 20-50ml, refluxed 30 minutes, filter, filtrate evaporate to dryness, residue add water 10ml makes dissolving, and hydro-oxidation sodium test solution is regulated pH value to 11-12, with ethyl acetate extraction 3 times, each 10ml merges ethyl acetate liquid, washes 3 times with dilute hydrochloric acid, each 10ml, merge pickle, add 40% sodium hydroxide solution, regulate pH value to 10-11, with ethyl acetate extraction 2 times, each 10ml merges ethyl acetate liquid, puts evaporate to dryness in the water-bath, residue adds ethyl acetate 1ml makes dissolving, as need testing solution; Other gets the tetrahydropalmatine reference substance, adds ethyl acetate and makes the solution that every 1ml contains 1mg, in contrast product solution; Test according to thin layer chromatography, draw each 5-15 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with normal hexane-chloroform-methanols of 7.5: 4: 1 was developing solvent, launched, and took out, dry, smoked clear with iodine vapor to the speckle colour developing, in air, wave the iodine that adsorbs on the most plate after, put under the ultra-violet lamp 365nm and inspect; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color;
E, to get preparation of the present invention a small amount of, adds methanol 10-30ml, supersound process 20 minutes, filter, filtrate evaporate to dryness, residue add water 10ml, and heating makes dissolving, use ethyl acetate extraction 3 times earlier, discard ethyl acetate liquid, reuse n-butyl alcohol 10ml jolting is extracted, and gets n-butyl alcohol liquid evaporate to dryness, residue adds methanol 1ml makes dissolving, as need testing solution; Other gets the Hesperidin reference substance, adds methanol and makes saturated solution, in contrast product solution; Test according to thin layer chromatography, draw each 2-10 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with 5: 3: 2: ethyl acetate-chloroform-methanol of 0.25: 0.5-formic acid-water was developing solvent, launch, take out, dry, spray is put under the ultra-violet lamp 365nm and is inspected with 1% aluminum chloride alcoholic solution; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color.
This product has replenishing QI to invigorate the spleen, disperse blood stasis and dredge collateral, the effect of blood nourishing and hair.Be used for insufficiency of the spleen leading to overabundance of dampness, the seborrheic alopecia of caused by energy stagnation and blood stasis and alopecia areata for determining drug effect, have been carried out pharmacodynamics test research to this product, and this product pill is prepared from according to optimal proportion of the present invention and best-of-breed technology scheme in the test.Concrete test is as follows:
Test the influence of a pair of rat hair growth
The test method rat is divided 4 groups at random: this product pill is low, by 2 times of equivalents of adult and 4 times of equivalents, the administration volume is 10ml/kg to high dose respectively; Alopecia Pill is by 2 times of administrations of adult's equivalent; The blank group is given the equal-volume distilled water.Each treated animal is in advance prior to back same area cropping, and the cropping area is 3 * 3cm, begins administration the same day in cropping, and be administered once every day, and continuous 7 days, cut newborn hair at cropping position last time on the 8th day, the electronic balance precision is weighed.The result shows that this product is low, high dose all can obviously promote cropping rat hair growth, and newborn gross weight amount sees Table 1 apparently higher than matched group.
Table 1 YANGXUE SHENGFA JIAONANG to the rat cropping after the influence of hair growth
| Group | Mus number (only) | Dosage (g/kg) | Newborn gross weight amount (mg) |
| Matched group | 12 | 60.0±12.5 | |
| The invention low dose group | 12 | 0.5 | 103.2±48.5* |
| The invention high dose group | 12 | 1.0 | 109.7±33.8** |
| The Alopecia Pill group | 12 | 2.70 | 92.5±17.6** |
Compare * p＜0.05, * * p＜0.01 with matched group
Test the influence of two pairs of mice hemorrhagic anemia models
Mice is except that normal group, other group mouse orbit blood sampling 0.4ml/ only, and detection erythrocyte and content of hemoglobin, next day is eye socket blood sampling 0.3ml once more, cause the hemorrhagic anemia model, cut the tail blood sampling again next day and survey erythrocyte and hemoglobin, be divided into 5 groups by the degree stratified random of losing blood, and the beginning administration.This product pill is low, by 2 times, 4 times equivalents of adult, mice administration volume is 20ml/kg to high dose respectively; Positive control drug fresh blood health-care capsule is by 2 times of administrations of adult's equivalent, and dosage is 0.55g/kg; The blank group is given the equal-volume distilled water.Successive administration 5 days was cut tail blood sampling survey erythrocyte and hemoglobin, and was carried out interpretation of result to deduct the preceding difference of treatment after the treatment on the 6th day.The result shows, pill of the present invention has the effect of tangible increase erythrocyte number and content of hemoglobin to mice hemorrhagic anemia model, sees Table 2.
The effect of table 2 pair mice hemorrhagic anemia model
| Group | Mus number (only) | After losing blood | After the treatment | Difference before and after the administration | |||
| Erythrocyte (* 10 12/L) | Hemoglobin (g/L) | Erythrocyte (* 10 12/L) | Hemoglobin (g/L) | Erythrocyte (* 10 12/L) | Hemoglobin (g/L) | ||
| Normal control | 14 | 7.59±0.85 | 186±22 | 7.66±0.74 | 188±18 | 0.10±0.94** | 2±24** |
| The model contrast | 14 | 4.54±0.54 | 115±12 | 6.19±0.96 | 136±20 | 1.66±0.80 | 20±16 |
| The invention low dosage | 14 | 4.30±0.62 | 98±12 | 6.27±0.84 | 120±19 | 1.96±0.88 | 23±11 |
| The invention high dose | 14 | 4.14±0.55 | 106±14 | 6.62±0.78 | 139±16 | 2.46±0.58* | 33±16* |
| New XUEBAO group | 14 | 4.38±0.57 | 111±14 | 7.36±0.92 | 163±22 | 2.98±0.72** | 52±15** |
Compare * P＜0.05, * * P＜0.01 with model group
Further specify technical scheme of the present invention by the following examples, but invention which is intended to be protected is not limited in the content described in the embodiment.
The specific embodiment:
Embodiment 1
[prescription] Radix Polygoni Multiflori 10g Radix Angelicae Sinensis 25g Cortex Magnoliae Officinalis 8g
Poria 7g Semen Plantaginis 7g Radix Saposhnikoviae 2g
Rhizoma Alismatis 7g Fructus Aurantii 52g Polyporus 10g
Radix Astragali 15g Pericarpium Citri Reticulatae Viride 15g Radix Codonopsis 35g
Flos Carthami 40g Semen Persicae 30g Radix Bupleuri 35g
Rhizoma Chuanxiong 50g Semen Coicis 35g Radix Paeoniae Rubra 30g
Herba Lycopi 33g Radix Salviae Miltiorrhizae 30g Rhizoma Corydalis 30g
Rhizoma Atractylodis 170g Rhizoma Atractylodis Macrocephalae 70g Herba Pogostemonis 37g
Herba Eupatorii 40g Pericarpium Citri Reticulatae 105g Rhizoma Pinelliae 10g
Radix Angelicae Dahuricae 50g Radix Platycodonis 30g
[method for making] above 29 flavors are ground into fine powder, sieve, and mixing divides packing, promptly.
Embodiment 2
[prescription] Radix Polygoni Multiflori (system) 7g Radix Angelicae Sinensis 24g Cortex Magnoliae Officinalis 10g
Poria 10g Semen Plantaginis 10g Radix Saposhnikoviae 3g
Rhizoma Alismatis 10g Fructus Aurantii 54g Polyporus 13g
Radix Astragali 17g Pericarpium Citri Reticulatae Viride 17g Radix Codonopsis 34g
Flos Carthami 37g Semen Persicae 34g Radix Bupleuri 34g
Rhizoma Chuanxiong 54g Semen Coicis 34g Radix Paeoniae Rubra 34g
Herba Lycopi 34g Radix Salviae Miltiorrhizae 34g Rhizoma Corydalis 34g
The Rhizoma Atractylodis 169g Rhizoma Atractylodis Macrocephalae (stir-fry) 67g Herba Pogostemonis 40g
The Herba Eupatorii 40g Pericarpium Citri Reticulatae 101g Rhizoma Pinelliae (clear system) 10g
Radix Angelicae Dahuricae 54g Radix Platycodonis 34g
[method for making] above 29 flavors are ground into fine powder, sieve, and mixing is made pill, drying, and packing, every bag of 5g, promptly.
This product fine powder is got in [discriminating] (1), puts microscopically and observes: pollen grain similar round, ellipse or olive shape, diameter be approximately to 60 μ m, 3 germinal aperatures of tool, and outer wall has dentation.Prism of calcium oxalate is present in the mesocarp parenchyma cell in flakes, is multiaspect shape, rhombus or biconial, diameter 3～34 μ m.Calcium oxalate cluster crystal is dispersed in or is present in the parenchyma cell, diameter 20～80 μ m.Irregular particle shape agglomerate and divide dendritic agglomerate colourless is met chloral hydrate liquid and is gradually dissolved, and hyphae colorless or light brown are elongated, and be crooked slightly.
(2) get this product 5g, porphyrize adds normal hexane 30ml, and supersound process 20 minutes filters, and filtrate volatilizes, and residue adds methanol 1ml makes dissolving, as need testing solution.Other gets Radix Angelicae Sinensis control medicinal material 1g, makes Radix Angelicae Sinensis control medicinal material solution with method, and Rhizoma Chuanxiong control medicinal material 1g makes Rhizoma Chuanxiong control medicinal material solution with method.According to the thin layer chromatography test, draw each 3 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, be developing solvent with normal hexane-ethyl acetate (19: 1), launch, take out, dry, put under the ultra-violet lamp (365nm) and inspect.In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, the fluorescence speckle of a same color is arranged.
(3) get Rhizoma Atractylodis control medicinal material 1g, add normal hexane 15ml, supersound process 20 minutes filters, and filtrate volatilizes, and residue adds methanol 2ml makes dissolving, in contrast medical material solution.Test according to thin layer chromatography, draw need testing solution and each 5 μ l of above-mentioned control medicinal material solution under the item of [discriminating] (2), put respectively on same silica gel g thin-layer plate, with petroleum ether (60～90 ℃)-ethyl acetate (20: 1) is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid of 5% paradime thylaminobenzaldehyde, and it is clear to be heated to the speckle colour developing.In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, the speckle of a same color is arranged.
(4) get this product 10g, porphyrize adds ammonia 5ml, flooded the 50ml that adds diethyl ether, reflux, extract, 30 minutes 30 minutes, filter, filtrate is extracted 2 times with the dilute hydrochloric acid jolting, each 15ml, merge acid liquid, add ammonia and transfer pH9～10, extract 3 times with the ether jolting, each 20ml merges ether solution, the low temperature evaporate to dryness, residue adds methanol 1ml makes dissolving, as need testing solution.Other gets the tetrahydropalmatine reference substance, adds methanol and makes the solution that every 1ml contains 0.5mg, in contrast product solution.Test according to thin layer chromatography, draw each 5 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with normal hexane-chloroform-methanol-triethylamine (10: 6: 1: 1) is developing solvent, launches, and takes out, dry, smoked clear with iodine vapor to the speckle colour developing, in air, wave the iodine that adsorbs on the most plate after, put under the ultra-violet lamp (365nm) and inspect.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color.
(5) get this product 5g, porphyrize adds methanol 20ml, and supersound process 20 minutes filters, and filtrate evaporate to dryness, residue add water 10ml, and heating makes dissolving, extracts 3 times with the ethyl acetate jolting, merges ethyl acetate liquid, and evaporate to dryness, residue add methanol 1ml makes dissolving, as need testing solution.Other gets the Hesperidin reference substance, adds methanol and makes saturated solution, in contrast product solution.Test according to thin layer chromatography, draw each 5 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with ethyl acetate-chloroform-methanol-formic acid-water (5: 3: 2: 0.25: 0.5) is developing solvent, launch, take out, dry, spray is put under the ultra-violet lamp (365nm) and is inspected with 1% aluminum chloride alcoholic solution.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color.
[assay] high effective liquid chromatography for measuring.
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile-water (21: 79) is a mobile phase; The detection wavelength is 284nm.Number of theoretical plate calculates by the Hesperidin peak should be not less than 4000.
It is an amount of that the preparation precision of reference substance solution takes by weighing the Hesperidin reference substance, adds methanol and make the solution that every 1ml contains 80 μ g, promptly.
2 bags of this product are got in the preparation of need testing solution, and porphyrize takes by weighing 0.5g, the accurate title, decide, and puts in the conical flask, and precision adds methanol 50ml, claim to decide weight, ultrasonic (power 250W, frequency 40kHz) handled 30 minutes, take out, put coldly, claim to decide weight, supply the weight that subtracts mistake with methanol, filter, get subsequent filtrate, filter with microporous filter membrane (0.45 μ m), promptly.
Accurate respectively reference substance solution and each the 10 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
This product contains Hesperidin (C for every bag
28H
34O
15) must not be less than 27.5mg.
Claims (9)
1. Chinese medicine composition for the treatment of seborrheic alopecia and alopecia areata is characterized in that this Chinese medicine composition made by following raw material medicaments:
Radix Polygoni Multiflori 5-10 weight portion Radix Angelicae Sinensis 20-25 weight portion Cortex Magnoliae Officinalis 7-12 weight portion
Poria 7-12 weight portion Semen Plantaginis 7-12 weight portion Radix Saposhnikoviae 1-5 weight portion
Rhizoma Alismatis 7-12 weight portion Fructus Aurantii 50-55 weight portion Polyporus 10-15 weight portion
Radix Astragali 15-20 weight portion Pericarpium Citri Reticulatae Viride 15-20 weight portion Radix Codonopsis 30-35 weight portion
Flos Carthami 35-40 weight portion Semen Persicae 30-35 weight portion Radix Bupleuri 30-35 weight portion
Rhizoma Chuanxiong 50-55 weight portion Semen Coicis 30-35 weight portion Radix Paeoniae Rubra 30-35 weight portion
Herba Lycopi 30-35 weight portion Radix Salviae Miltiorrhizae 30-35 weight portion Rhizoma Corydalis 30-35 weight portion
Rhizoma Atractylodis 165-170 weight portion Rhizoma Atractylodis Macrocephalae 65-70 weight portion Herba Pogostemonis 37-45 weight portion
Herba Eupatorii 37-45 weight portion Pericarpium Citri Reticulatae 100-105 weight portion Rhizoma Pinelliae 7-12 weight portion
Radix Angelicae Dahuricae 50-55 weight portion Radix Platycodonis 30-35 weight portion.
2. Chinese medicine composition according to claim 1 is characterized in that the best proportioning of each crude drug is:
Radix Polygoni Multiflori 7 weight portion Radix Angelicae Sinensis 24 weight portion Cortex Magnoliae Officinalis 10 weight portions
Poria 10 weight portion Semen Plantaginiss 10 weight portion Radix Saposhnikoviaes 3 weight portions
Rhizoma Alismatis 10 weight portion Fructus Aurantiis 54 weight portion Polyporus 13 weight portions
The Radix Astragali 17 weight portion Pericarpium Citri Reticulatae Virides 17 weight portion Radix Codonopsis 34 weight portions
Flos Carthami 37 weight portion Semen Persicaes 34 weight portion Radix Bupleuri 34 weight portions
Rhizoma Chuanxiong 54 weight portion Semen Coiciss 34 weight portion Radix Paeoniae Rubra 34 weight portions
Herba Lycopi's 34 weight portion Radix Salviae Miltiorrhizaes 34 weight portion Rhizoma Corydalis 34 weight portions
The Rhizoma Atractylodis 169 weight portion Rhizoma Atractylodis Macrocephalaes 67 weight portion Herba Pogostemonis 40 weight portions
The Herba Eupatorii 40 weight portion Pericarpium Citri Reticulataes 101 weight portion Rhizoma Pinelliaes 10 weight portions
The Radix Angelicae Dahuricae 54 weight portion Radix Platycodoniss 34 weight portions.
3. Chinese medicine composition as claimed in claim 1 or 2 is characterized in that the Radix Polygoni Multiflori in the crude drug is preferably Radix Polygoni Multiflori Preparata, and the Rhizoma Atractylodis Macrocephalae is preferably Rhizoma Atractylodis Macrocephalae (parched), and the Rhizoma Pinelliae is preferably Rhizoma Pinelliae Preparata clearly.
4. as claim 1,2 or 3 described Chinese medicine compositions, it is characterized in that this Chinese medicine composition can make preparation commonly used on clinical or the pharmaceutics, comprise tablet, powder, capsule, soft capsule, pill etc.
5. as the preparation method of Chinese medicine composition as described in each in the claim 1 to 4, it is characterized in that this method is: get crude drug, be ground into fine powder, add suitable adjuvant, make required dosage form.
6. as the preparation method of Chinese medicine composition as described in the claim 5, it is characterized in that wherein the preparation method of pill is: get crude drug, be ground into fine powder, cross 100 mesh sieves, mixing is made pill.
7. as the method for quality control of Chinese medicine composition as described in each in the claim 1 to 4, it is characterized in that this method comprises one or more the combination in the following content assaying method:
A, high effective liquid chromatography for measuring Determination of Hesperidin Content
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; 15: 85-25: 75 acetonitrile-water is a mobile phase; The detection wavelength is 284 ± 2nm; Number of theoretical plate calculates by the Hesperidin peak should be not less than 2000;
It is an amount of that the preparation precision of reference substance solution takes by weighing the Hesperidin reference substance, adds methanol and make the solution that every 1ml contains 50-100 μ g, promptly;
It is an amount of that this product is got in the preparation of need testing solution, accurate claims surely, puts in the conical flask, and precision adds methanol 25-100ml, claim decide weight, and supersound process 20-40 minute, take out, put coldly, claim to decide weight, supply the weight that subtracts mistake with methanol, filtration is got subsequent filtrate, promptly;
Accurate respectively reference substance solution and each the 5-10 μ l of need testing solution of drawing of algoscopy injects chromatograph of liquid, measures, promptly;
B, high effective liquid chromatography for measuring content of paeoniflorin
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; 10: 90-20: 80 acetonitrile-0.1 phosphoric acid is mobile phase, detects wavelength 230 ± 2nm; Number of theoretical plate calculates by the peoniflorin peak should be not less than 1500;
It is an amount of that the preparation precision of the preparation reference substance solution of reference substance solution takes by weighing in phosphorus pentoxide desiccator 36 hours peoniflorin reference substance of drying under reduced pressure, adds mobile phase and make the solution that contains 40-60 μ g among every 1ml, shakes up, promptly;
It is an amount of that this product is got in the preparation of need testing solution, and accurate the title decides, and the accurate methanol 25-100ml that adds claims to decide weight, and supersound process 20-40 minute, claim again to decide weight, add methanol and supply the weight that subtracts mistake, filtration, promptly;
Accurate respectively reference substance solution and each the 5-10 μ l of need testing solution of drawing of algoscopy injects chromatograph of liquid, measures, promptly;
C, high effective liquid chromatography for measuring 2,3,5, the content of 4 '-tetrahydroxystilbene 2-O-β-D-glucoside
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; 10: 90-20: 80 acetonitrile-water is a mobile phase; The detection wavelength is 320 ± 2nm; Number of theoretical plate by 2,3,5,4 '-tetrahydroxystilbene-2-O-β-D-glucoside peak calculates, and should be not less than 2000;
The preparation precision of reference substance solution takes by weighing 2,3,5,4 '-tetrahydroxystilbene-2-O-β-D-glucoside reference substance is an amount of, and add the mobile phase dissolving and make the reference substance solution that every 1ml contains 10-30 μ g, promptly;
It is an amount of that this product is got in the preparation of need testing solution, accurate claims surely, and the accurate Diluted Alcohol 100ml that adds claims decide weight, and supersound process 20-40 minute, put coldly, claim again to decide weight, supply the weight that subtracts mistake with Diluted Alcohol, filtration adds mobile phase to scale, shakes up, promptly;
Accurate respectively reference substance solution and each the 5-10 μ l of need testing solution of drawing of algoscopy injects chromatograph of liquid, measures, promptly.
8. as the method for quality control of Chinese medicine composition as described in the claim 7, it is characterized in that this method comprises following one or more discrimination methods:
A, to get preparation of the present invention a small amount of, puts microscopically and observe: pollen grain similar round, ellipse or olive shape, diameter be approximately to 60 μ m, 3 germinal aperatures of tool, and outer wall has dentation; Prism of calcium oxalate is present in the mesocarp parenchyma cell in flakes, is multiaspect shape, rhombus or biconial, diameter 3～34 μ m; Calcium oxalate cluster crystal is dispersed in or is present in the parenchyma cell, diameter 20～80 μ m; Irregular particle shape agglomerate and divide dendritic agglomerate colourless is met chloral hydrate liquid and is gradually dissolved, and hyphae colorless or light brown are elongated, and be crooked slightly;
B, to get preparation of the present invention a small amount of, the 20-50ml that adds diethyl ether, and reflux 1 hour filters, and filtrate volatilizes, and the residue 2ml that adds diethyl ether makes dissolving, as need testing solution; Other gets Radix Angelicae Sinensis control medicinal material 1g, shines medical material solution in pairs with legal system; According to the thin layer chromatography test, draw each 2-5 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, be developing solvent with normal hexane-ethyl acetates of 19: 1, launch, take out, dry, put under the ultra-violet lamp 365nm and inspect; In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color;
C, to get preparation of the present invention a small amount of, the 20-50ml that adds diethyl ether, and reflux 1 hour filters, and filtrate volatilizes, and the residue 2ml that adds diethyl ether makes dissolving, as need testing solution; Get Rhizoma Atractylodis control medicinal material 1g, the 15ml that adds diethyl ether, reflux 1 hour filters, and filtrate volatilizes, and the residue 2ml that adds diethyl ether makes dissolving, in contrast medical material solution; According to the thin layer chromatography test, draw each 2-10 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with the normal hexane is developing solvent, launches, and takes out, dry, spray is with 10% ethanol solution of sulfuric acid of 5% paradime thylaminobenzaldehyde, and it is clear to be heated to the speckle colour developing; In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the speckle of same color;
D, to get preparation of the present invention a small amount of, adds methanol 20-50ml, refluxed 30 minutes, filter, filtrate evaporate to dryness, residue add water 10ml makes dissolving, and hydro-oxidation sodium test solution is regulated pH value to 11-12, with ethyl acetate extraction 3 times, each 10ml merges ethyl acetate liquid, washes 3 times with dilute hydrochloric acid, each 10ml, merge pickle, add 40% sodium hydroxide solution, regulate pH value to 10-11, with ethyl acetate extraction 2 times, each 10ml merges ethyl acetate liquid, puts evaporate to dryness in the water-bath, residue adds ethyl acetate 1ml makes dissolving, as need testing solution; Other gets the tetrahydropalmatine reference substance, adds ethyl acetate and makes the solution that every 1ml contains 1mg, in contrast product solution; Test according to thin layer chromatography, draw each 5-15 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with normal hexane-chloroform-methanols of 7.5: 4: 1 was developing solvent, launched, and took out, dry, smoked clear with iodine vapor to the speckle colour developing, in air, wave the iodine that adsorbs on the most plate after, put under the ultra-violet lamp 365nm and inspect; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color;
E, to get preparation of the present invention a small amount of, adds methanol 10-30ml, supersound process 20 minutes, filter, filtrate evaporate to dryness, residue add water 10ml, and heating makes dissolving, use ethyl acetate extraction 3 times earlier, discard ethyl acetate liquid, reuse n-butyl alcohol 10ml jolting is extracted, and gets n-butyl alcohol liquid evaporate to dryness, residue adds methanol 1ml makes dissolving, as need testing solution; Other gets the Hesperidin reference substance, adds methanol and makes saturated solution, in contrast product solution; Test according to thin layer chromatography, draw each 2-10 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with 5: 3: 2: ethyl acetate-chloroform-methanol of 0.25: 0.5-formic acid-water was developing solvent, launch, take out, dry, spray is put under the ultra-violet lamp 365nm and is inspected with 1% aluminum chloride alcoholic solution; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color.
9. be used for the treatment of application in the medicine of seborrheic alopecia and alopecia areata as Chinese medicine composition as described in the claim 1,2 or 3 in preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005102003842A CN100493579C (en) | 2005-07-08 | 2005-07-08 | Chinese medicine composition, and its preparing method and quality control method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005102003842A CN100493579C (en) | 2005-07-08 | 2005-07-08 | Chinese medicine composition, and its preparing method and quality control method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1891284A true CN1891284A (en) | 2007-01-10 |
| CN100493579C CN100493579C (en) | 2009-06-03 |
Family
ID=37596645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005102003842A Expired - Fee Related CN100493579C (en) | 2005-07-08 | 2005-07-08 | Chinese medicine composition, and its preparing method and quality control method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100493579C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199817B (en) * | 2007-12-11 | 2010-08-25 | 周鑫 | Liver-protecting fat-dropping tea |
| CN101966307A (en) * | 2010-10-26 | 2011-02-09 | 长治市郊区人民医院 | Medicinal composition for treating damp-heat icterohepatitis |
| CN101822629B (en) * | 2010-02-05 | 2011-08-17 | 霸王（广州）有限公司 | Special pure natural plant thick hair essence for men and preparation method thereof |
| CN105031113A (en) * | 2015-07-08 | 2015-11-11 | 江苏奇力康皮肤药业有限公司 | Traditional Chinese medicine aqua for preventing alopecia and preparation method thereof |
| CN112083097A (en) * | 2020-09-09 | 2020-12-15 | 四川新绿色药业科技发展有限公司 | Thin-layer identification method for simultaneously identifying ferulic acid, calycosin glucoside and hesperidin |
| CN115184500A (en) * | 2022-07-19 | 2022-10-14 | 康臣药业(霍尔果斯)有限公司 | Quality detection method of traditional Chinese medicine composition |
-
2005
- 2005-07-08 CN CNB2005102003842A patent/CN100493579C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199817B (en) * | 2007-12-11 | 2010-08-25 | 周鑫 | Liver-protecting fat-dropping tea |
| CN101822629B (en) * | 2010-02-05 | 2011-08-17 | 霸王（广州）有限公司 | Special pure natural plant thick hair essence for men and preparation method thereof |
| CN101966307A (en) * | 2010-10-26 | 2011-02-09 | 长治市郊区人民医院 | Medicinal composition for treating damp-heat icterohepatitis |
| CN105031113A (en) * | 2015-07-08 | 2015-11-11 | 江苏奇力康皮肤药业有限公司 | Traditional Chinese medicine aqua for preventing alopecia and preparation method thereof |
| CN112083097A (en) * | 2020-09-09 | 2020-12-15 | 四川新绿色药业科技发展有限公司 | Thin-layer identification method for simultaneously identifying ferulic acid, calycosin glucoside and hesperidin |
| CN115184500A (en) * | 2022-07-19 | 2022-10-14 | 康臣药业(霍尔果斯)有限公司 | Quality detection method of traditional Chinese medicine composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100493579C (en) | 2009-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1806846A (en) | Chinese medicinal composition, its preparation process and quality control method | |
| CN101073606A (en) | Method for separating and extracting white Peony Root | |
| CN1891284A (en) | Chinese medicine composition, and its preparing method and quality control method | |
| CN102362978A (en) | Chinese medicinal composition having effects of tonifying kidney, replenishing essence, replenishing qi and nourishing blood | |
| CN1762465A (en) | Rhinitis gel, its preparation method and quality control technology | |
| CN101057925A (en) | Preparation technology for 'jieguqili' capsule and its quality control method | |
| CN100415258C (en) | Chinese traditional medicine composition for treating leucopenia and preparation and quality controlling method thereof | |
| CN1850208A (en) | Quality control method for ass-skin glue blood-supplementing preparation | |
| CN1283281C (en) | Medicinal composition containing wild jujube seed, lucid ganoderma and ginseng leaf and its preparing process and use | |
| CN1879720A (en) | Blood platelet-increasing tablet, its preparation process and quality control method | |
| CN100336544C (en) | Chinese medicinal composition with beautifying function and method for preparing the same | |
| CN1923263A (en) | Traditional Chinese medicine composition, its preparing method and quality controlling means | |
| CN1319573C (en) | Chinese medicine composition for treating osteoporosis and preparing method | |
| CN1887324A (en) | Chinese composition and its prepn process and quality control method | |
| CN1219532C (en) | Chinese herbal medicine for treating gynecology disease and its preparing method | |
| CN1309372C (en) | Preparation of granular powder for treating hepatitis and quality control method | |
| CN1586612A (en) | Process for preparing granular powder for treating blood stasis disease and quality control method | |
| CN1672721A (en) | Immunity raising Chinese medicine and its prepn process | |
| CN1241586C (en) | Chinese medicine composition and preparing method thereof | |
| CN1836712A (en) | Pharmaceutical composition for treating sexual disorder and its preparation process | |
| CN1309373C (en) | Granular preparation for treating cancer and its quality control method | |
| CN103655821A (en) | Traditional Chinese medicine preparation with effects of benefiting Qi and raising Yang as well as replenishing essence and tonifying marrow and preparation method of traditional Chinese medicine preparation | |
| CN1891283A (en) | Chinese medicine composition, and its preparing method and quality control method | |
| CN1923268B (en) | Medicinal composition for treating rhinitis, its preparing method and quality controlling means | |
| CN1695713A (en) | Medication for treating diabetes and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090603 Termination date: 20140708 |
|
| EXPY | Termination of patent right or utility model |